论文部分内容阅读
为解决扁桃体、增殖体及增殖体扁桃体切除术是否安全这一问题,回顾1987年3月至1990年4月间手术3 488例,其中增殖体扁桃体切除术1 019例,扁桃体切除术1 072例,增殖体切除术1397例。因为手术后最严重的并发症为反应性出血,共有17例术后出血(0.49%),其中9例为增殖体扁桃体切除。2例扁桃体切除、6例增殖体切除。9例增殖体扁桃体切除的出血部位分别为:增殖体床5例,增殖体床及扁桃体床均有3例,扁桃体床1例。总计出血部位为:增殖体床11例(65%),扁桃体床3例(17.5%),两处均有出血3例(17.5%)。
To address the issue of the safety of tonsil, proliferative and proliferative tonsillectomy, 3 488 surgeries between March 1987 and April 1990 were reviewed, of which 1 019 were proliferative tonsillectomy and 1 072 with tonsillectomy , 1397 cases of proliferative resection. Because the most serious complication after surgery was reactive hemorrhage, there were 17 postoperative bleeding episodes (0.49%), of which 9 were proliferative tonsillectomy. 2 cases of tonsillectomy, 6 cases of proliferative resection. Nine cases of proliferative tonsillectomy bleeding sites were: proliferating body bed in 5 cases, 3 cases of proliferative and tonsil bed, tonsil bed in 1 case. The total bleeding sites were: proliferative body bed in 11 cases (65%), tonsil bed in 3 cases (17.5%), and bleeding in both of the three cases (17.5%).